CompaniesByCap
CLB
Core Laboratories Inc. (CLB)
NYSE

Core Laboratories Inc. EBITDA 2021–2025

Core Laboratories Inc. annual/quarterly ebitda history and growth rate from 2021 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.

  • Core Laboratories Inc. ebitda for the quarter ending March 31, 2026 was 5.7 M, a 30.53% decrease year-over-year.
  • Core Laboratories Inc. ebitda for the twelve months ending March 31, 2026 was 57.3 M, a 22.89% decrease year-over-year.
  • Core Laboratories Inc. annual ebitda for 2025 was 71.1 M, a 3.25% decrease from 2024.
  • Core Laboratories Inc. annual ebitda for 2024 was 73.5 M, a 4.38% increase from 2023.
  • Core Laboratories Inc. annual ebitda for 2023 was 70.4 M, a 20.00% increase from 2022.
  • Core Laboratories Inc. annual ebitda for 2022 was 58.7 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Core Laboratories Inc. EBITDA — FAQ

Core Laboratories Inc. (CLB) ebitda over the last 5 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see CLB's ebitda history?

The chart and table above show Core Laboratories Inc.'s ebitda by year and by quarter, including the growth rate.